Jun. 8 at 12:00 AM
I used Claude AI per the following information since investors often reference the comparison between NAC & Buci...If Buci is eventually approved -- My opinion is that NAC has already helped forged a positive path for market acceptance & revenue...
$RVVTF 📊 NAC 2026 Market Value
Supplement-focused market: The global NAC supplements market is valued at approximately
$1.22 billion in 2025, and is projected to grow to
$5.11 billion by 2035, at a CAGR of 15.6% from 2026 to 2035.
Broader pharma + supplement market: The combined global N-Acetylcysteine market was valued at
$1.84 billion in 2024 and is projected to grow from
$2.25 billion in 2025 to
$11.35 billion by 2033, at a CAGR of 22.4%. GI Research
North America is the dominant region: North America held over 38.6% market share in 2025, generating approximately
$472 million in revenue.
Let's hope for approval soon staying positive remembering that the Martini Glass is always 1/2 full -- Not 1/2 empty... ;)